Kevin Anderson in

Kevin Anderson

Login to view DISC.
Founder & Principal | Applied AI Strategy and Pharma GTM Advisor at Avery & Riley
📍 Greater Boston, United States

Kevin Anderson is a clinical development executive who founded Avery & Riley to advise biotech companies on applied AI strategy. With a career spanning roles at Moderna, Alexion, and Amgen, he focuses on integrating AI to solve operational bottlenecks in drug development. He holds an MBA from Boston College.

Kevin is deeply involved in the broader biotech community, having served as Co-Chair of MassBios Biostats, Data Management & Clinical Trials Working Group. He also contributes to the Clinical AI Innovators Network, a community for professionals advancing AI in drug development.

His advisory firm, Avery & Riley, is named after the middle names of his two daughters, reflecting a personal standard of judgment and integrity.

Read the full overview →
Experience
12 Years
Current Role
Founder & Principal | Applied AI Strategy and Pharma GTM Advisor
Job Level
Leadership
Location
Greater Boston, United States
Personality Overview

How Kevin shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Kevin cares about

AI in Pharma
His current firm, Avery & Riley, focuses on advising biotech and pharma companies on practical AI adoption, governance, and go-to-market strategy for AI solutions.
Clinical Operations
He has over 25 years of experience leading global clinical operations, managing Phase 1-3 studies, and has successfully navigated multiple regulatory inspections across various agencies.
+4 more topics Login to view topics
Career

Work history

2-2026
Founder & Principal | Applied AI Strategy and Pharma GTM Advisor
Avery & Riley
5-2024 - 2-2026
Sr. Director, Clinical Operations
Moderna
10-2022 - 4-2024
Sr. Director, Clinical Operations. (Company Closed)
AlloVir
8-2021 - 8-2022
Sr. Director, Clinical Operations
PTC Therapeutics, Inc.
3-2017 - 8-2021
Director, Global Clinical Operations
Alexion Pharmaceuticals, Inc.
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Master of Business Administration (MBA)
Boston College Carroll School of Management
BA
Eastern University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Kevin. Free, 10 seconds.